title: Cutaneous aspergillosis and acquired immunodeficiency syndrome.
abstract: BACKGROUND
  Primary cutaneous aspergillosis is an uncommon finding in patients with acquired immunodeficiency syndrome (AIDS); only 13 cases have been reported in the literature.
  
  
  METHODS
  We describe 11 patients with primary cutaneous aspergillosis and AIDS. There does not seem to be an age, sex, race, or human immunodeficiency virus risk factor predisposition. This is a late manifestation of AIDS; patients typically have low CD4 counts (<0.050 x 10(9)/L [<50/microL]) and other AIDS-defining illnesses. The most frequent presentation is in patients with cytomegalovirus disease and neutropenia caused by ganciclovir therapy. Lesions developed at the site of occlusive dressings for an indwelling intravenous catheter site in 10 patients. Neutrophil counts may be normal at the time of diagnosis. A minor presentation is in the patient without neutropenia as a result of traumatic inoculation. Histological findings and/or culture results are required for diagnosis. Patients develop cutaneous lesions despite prophylactic therapy with fluconazole. Lesions can be treated with excision and lifelong therapy with itraconazole.
  
  
  CONCLUSIONS
  Because of the potential morbidity and mortality of cutaneous aspergillosis, a high level of suspicion and prompt institution of therapy is required.
authors.affiliation: Department of Dermatology, University of California, San Francisco, USA. murakag@mail.amc.edu
authors.forename: G J
authors.initials: GJ
authors.lastname: Murakawa
authors.forename: J D
authors.initials: JD
authors.lastname: Harvell
authors.forename: P
authors.initials: P
authors.lastname: Lubitz
authors.forename: S
authors.initials: S
authors.lastname: Schnoll
authors.forename: S
authors.initials: S
authors.lastname: Lee
authors.forename: T
authors.initials: T
authors.lastname: Berger
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000150:complications* / Q000188:drug therapy; D000328:Adult; D000935:Antifungal Agents / Q000627:therapeutic use; D001228:Aspergillosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D002408:Catheters, Indwelling / Q000009:adverse effects; D003881:Dermatomycoses / Q000150:complications* / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009779:Occlusive Dressings / Q000009:adverse effects
chemical_list: D000935:Antifungal Agents; D017964:Itraconazole